South African runner Caster Semenya on Wednesday lost her court challenge against IAAF rules forcing some female athletes to regulate their testosterone levels, but judges voiced concern with the "discriminatory" regulations.
The decision by the Court of Arbitration for Sport means that women with elevated testosterone will have to take suppressive treatment if they wish to compete as females in certain events.
The verdict triggered emotional reactions following a charged legal battle over increasingly complex questions of gender, which are likely to have far-reaching consequences for the future of women's sport.
In a 2-1 decision, CAS judges dismissed Semenya's appeal against measures imposed by the International Association of Athletics Federations (IAAF) targeting "hyperandrogenic" athletes -- or those with "differences of sexual development" (DSD).
The judges said that although the rules are "discriminatory...such discrimination is a necessary, reasonable and proportionate means of achieving the IAAF's aim of preserving the integrity of female athletics in the Restricted Events."
In a statement issued by her lawyers, the 28-year-old double Olympic champion Semenya said that "for a decade the IAAF has tried to slow me down."
"But this has actually made me stronger. The decision of the CAS will not hold me back. I will once again rise above and continue to inspire young women and athletes in South Africa and around the world."
South Africa, which has accused the IAAF of seeking to violate women's bodies, said it was "disappointed" with the judgement.
The IAAF said it was "grateful" for the verdict and that the DSD rules -- first adopted last year but suspended pending the legal battle -- will come into affect on May 8.
- 'Serious concerns' -
The athletics governing body has maintained that the rules are necessary to ensure all female athletes can see "a path to success".
It has stressed that DSD athletes with male levels of testosterone benefit from increased bone and muscle strength similar to men who have gone through puberty.
While the court said there was insufficient evidence to overturn the regulations, it "expressed some serious concerns as to the future practical application of these DSD Regulations."
The rules must remain a "living document," which are revised based on new information, the court added.
Judges specifically raised the issue of "unintentional non-compliance," given the difficulty of maintaining artificial testosterone levels, and possible side-effects of mandated hormone treatment.
And the court suggested the rules should not be applied to longer events like the 1500 metres because there was insufficient evidence to indicate that hyperandrogenic athletes had an advantage.
The testosterone rules will however apply to the 800 metre race, an event Semenya has dominated over the last decade.
In order to defend her title at the world championships in September, Semenya will have to take medication, likely including birth control pills.
- 'Humiliating, harmful' -
Some experts have argued that achieving excellence in sport is a combination of training and commitment as well as genetics, and that barring people from competition over a single genetic factor has no scientific basis.
In a rare intrusion into the world of sport, the United Nations Human Rights Council adopted a resolution in March branding the IAAF rules "unnecessary, humiliating and harmful".
Seema Patel, a senior lecturer in law at Nottingham Law School, criticised the CAS ruling for green-lighting "unethical medical procedures."
"A female who has naturally higher levels of testosterone in her body should not be prohibited from competing with women, just as a female who is naturally taller than the average woman should not be prohibited," Patel said in a statement.
Patel also questioned whether a sports court had the competence to deal with "human rights matters."
Semenya's testosterone levels are not publicly known, but she is unlikely to be the only athlete affected by rules compelling female runners in certain categories to cap their testosterone levels at five nanomoles per litre (nmol/L) of blood.
The two athletes who finished behind her in the Rio Olympics 800m, Francine Niyonsaba of Burundi and Kenya's Margaret Wambui, have also faced questions about their testosterone levels.
Semenya is weighing an appeal, her statement said. Such a challenge needs to be filed at the Swiss Federal Tribunal within 30 days.
South African runner Caster Semenya on Wednesday lost her court challenge against IAAF rules forcing some female athletes to regulate their testosterone levels, but judges voiced concern with the “discriminatory” regulations.
The decision by the Court of Arbitration for Sport means that women with elevated testosterone will have to take suppressive treatment if they wish to compete as females in certain events.
The verdict triggered emotional reactions following a charged legal battle over increasingly complex questions of gender, which are likely to have far-reaching consequences for the future of women’s sport.
In a 2-1 decision, CAS judges dismissed Semenya’s appeal against measures imposed by the International Association of Athletics Federations (IAAF) targeting “hyperandrogenic” athletes — or those with “differences of sexual development” (DSD).
The judges said that although the rules are “discriminatory…such discrimination is a necessary, reasonable and proportionate means of achieving the IAAF’s aim of preserving the integrity of female athletics in the Restricted Events.”
In a statement issued by her lawyers, the 28-year-old double Olympic champion Semenya said that “for a decade the IAAF has tried to slow me down.”
“But this has actually made me stronger. The decision of the CAS will not hold me back. I will once again rise above and continue to inspire young women and athletes in South Africa and around the world.”
South Africa, which has accused the IAAF of seeking to violate women’s bodies, said it was “disappointed” with the judgement.
The IAAF said it was “grateful” for the verdict and that the DSD rules — first adopted last year but suspended pending the legal battle — will come into affect on May 8.
– ‘Serious concerns’ –
The athletics governing body has maintained that the rules are necessary to ensure all female athletes can see “a path to success”.
It has stressed that DSD athletes with male levels of testosterone benefit from increased bone and muscle strength similar to men who have gone through puberty.
While the court said there was insufficient evidence to overturn the regulations, it “expressed some serious concerns as to the future practical application of these DSD Regulations.”
The rules must remain a “living document,” which are revised based on new information, the court added.
Judges specifically raised the issue of “unintentional non-compliance,” given the difficulty of maintaining artificial testosterone levels, and possible side-effects of mandated hormone treatment.
And the court suggested the rules should not be applied to longer events like the 1500 metres because there was insufficient evidence to indicate that hyperandrogenic athletes had an advantage.
The testosterone rules will however apply to the 800 metre race, an event Semenya has dominated over the last decade.
In order to defend her title at the world championships in September, Semenya will have to take medication, likely including birth control pills.
– ‘Humiliating, harmful’ –
Some experts have argued that achieving excellence in sport is a combination of training and commitment as well as genetics, and that barring people from competition over a single genetic factor has no scientific basis.
In a rare intrusion into the world of sport, the United Nations Human Rights Council adopted a resolution in March branding the IAAF rules “unnecessary, humiliating and harmful”.
Seema Patel, a senior lecturer in law at Nottingham Law School, criticised the CAS ruling for green-lighting “unethical medical procedures.”
“A female who has naturally higher levels of testosterone in her body should not be prohibited from competing with women, just as a female who is naturally taller than the average woman should not be prohibited,” Patel said in a statement.
Patel also questioned whether a sports court had the competence to deal with “human rights matters.”
Semenya’s testosterone levels are not publicly known, but she is unlikely to be the only athlete affected by rules compelling female runners in certain categories to cap their testosterone levels at five nanomoles per litre (nmol/L) of blood.
The two athletes who finished behind her in the Rio Olympics 800m, Francine Niyonsaba of Burundi and Kenya’s Margaret Wambui, have also faced questions about their testosterone levels.
Semenya is weighing an appeal, her statement said. Such a challenge needs to be filed at the Swiss Federal Tribunal within 30 days.
